Melanoma Research Victoria

Source: Medscape, May 2019 This transcript has been edited for clarity. Hello. I am Dr Jeffrey Weber. I’m deputy director of and a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City. Today I will be discussing a very interesting study that was recently reported in […]

Read the full story

Source: Modern Medicine Network, May 2019 Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy.

Read the full story

Source: OncLive, May 2019 Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy in patients with melanoma. This biggest advancement in this treatment paradigm over the last several years has been the advent of combination therapies, Johnson says. […]

Read the full story

Source: OncLive, May 2019 Ryan J. Sullivan, MD, assistant professor of medicine, Harvard Medical School, assistant professor of medicine, Hematology/Oncology, Massachusetts General Hospital (MGH), MGH Cancer Center, discusses findings from the ENCORE 601 trial in melanoma. In the phase Ib/II ENCORE 601 trial presented at the 2019 AACR Annual Meeting, investigators presented the interim results […]

Read the full story